VitalSigns
Return to the Blog Homepage

Tag Archives: drugs

February 20, 2017

0 Comments

Written by

Categories: FDA News, Healthcare, The Week That Was

Tags: , ,

The Week That Was: Crises in Communications

Whether your cultural point of reference is Jay-Z or Annie!, we can all agree that last week was a “hard knock life” for orphans…orphan drugs, that is. We saw Marathon hit pause on its launch of Emflaza, the steroid approved...

October 4, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: ,

The Week That Was: Crises in Communications

WARNING: We’re getting into heavy stuff this week, like compassionate use, 340B pricing policy and value frameworks, but we promise you don’t need to be an economics Ph.D. to follow along. We often get asked to pull out our crystal...